GPT and COVID-19: The majority of patients experiencing COVID-19 develop abnormal liver function (6–8), with studies reporting abnormal alanine transaminase (ALT), aspartate aminotransferase (AST), albumin levels, and increased gamma-glutamyl transferase (GGT) in severe patients (7).